TipRanks
Alligator Bioscience AB (GB:0RK9)
LSE:0RK9
UK Market
0RK9
Alligator Bioscience AB
RESEARCH TOOLSreports

Alligator Bioscience AB (0RK9) Ratios

1 Followers

Alligator Bioscience AB Ratios

GB:0RK9's free cash flow for Q3 2026 was kr-62.80. For the 2026 fiscal year, GB:0RK9's free cash flow was decreased by kr and operating cash flow was kr-83.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.02 0.88 0.35 0.79 1.90
Quick Ratio
 1.02 0.88 0.35 0.79 1.90
Cash Ratio
 0.87 0.80 0.32 0.67 1.51
Solvency Ratio
 -1.22 -0.59 -0.79 -2.23 -2.26
Operating Cash Flow Ratio
 -2.05 -2.00 -1.05 -1.91 -2.67
Short-Term Operating Cash Flow Coverage
 -10.93 -18.69 0.00 0.00 0.00
Net Current Asset Value
kr -18.02Mkr -35.08Mkr -163.53Mkr -28.41Mkr 42.28M
Leverage Ratios
Debt-to-Assets Ratio
 0.31 0.39 0.42 0.14 0.14
Debt-to-Equity Ratio
 1.20 6.29 -0.33 1.36 0.28
Debt-to-Capital Ratio
 0.55 0.86 -0.50 0.58 0.22
Long-Term Debt-to-Capital Ratio
 0.00 0.79 0.00 0.00 0.00
Financial Leverage Ratio
 3.86 16.13 -0.80 9.99 1.90
Debt Service Coverage Ratio
 -2.95 -2.32 -8.40 -491.95 -280.16
Interest Coverage Ratio
 -4.11 -2.76 -11.64 -515.49 -298.43
Debt to Market Cap
 16.94 3.66 0.00 0.00 0.00
Interest Debt Per Share
 0.08 3.18 7.28 3.13 3.81
Net Debt to EBITDA
 0.14 0.16 0.13 0.21 0.40
Profitability Margins
Gross Profit Margin
-13515.90%-10665.18%100.00%100.00%-313.84%
EBIT Margin
-34256.89%-21738.13%-370.80%-426.98%-540.00%
EBITDA Margin
-33895.41%-23731.71%-286.45%-408.92%-507.03%
Operating Profit Margin
-34256.89%-23780.54%-396.66%-428.49%-540.09%
Pretax Profit Margin
-29011.31%-9990.27%-404.89%-427.81%-541.81%
Net Profit Margin
-29011.31%-9990.27%-404.89%-427.81%-541.79%
Continuous Operations Profit Margin
-29011.31%-9990.27%-404.89%-427.81%-541.81%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
84.69%42.01%102.07%99.84%100.32%
Return on Assets (ROA)
-91.83%-46.43%-224.17%-209.87%-114.04%
Return on Equity (ROE)
-439.98%-748.65%179.11%-2096.89%-217.18%
Return on Capital Employed (ROCE)
-230.54%-376.59%235.95%-1285.34%-183.51%
Return on Invested Capital (ROIC)
-190.26%-244.42%263.33%-890.75%-169.77%
Return on Tangible Assets
-166.41%-72.80%-305.85%-247.38%-127.60%
Earnings Yield
-1320.34%-553.71%-10.82%-6.80%-1.89%
Efficiency Ratios
Receivables Turnover
 0.04 0.08 79.57 29.05K 1.96
Payables Turnover
 11.76 12.09 23.88 0.00 11.07
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.25 0.27 19.12 2.86 1.33
Asset Turnover
 <0.01 <0.01 0.55 0.49 0.21
Working Capital Turnover Ratio
 -0.04 >-0.01 -0.77 3.11 0.23
Cash Conversion Cycle
 8.94K 4.56K -10.69 0.01 153.09
Days of Sales Outstanding
 8.97K 4.59K 4.59 0.01 186.06
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 31.04 30.18 15.28 0.00 32.97
Operating Cycle
 8.97K 4.59K 4.59 0.01 186.06
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.15 -5.67 -24.46 -35.68 -26.18
Free Cash Flow Per Share
 -0.15 -5.72 -24.46 -36.15 -26.25
CapEx Per Share
 0.00 0.05 0.00 0.46 0.07
Free Cash Flow to Operating Cash Flow
 1.00 1.01 1.00 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 -106.77 0.00 -76.98 -392.29
Capital Expenditure Coverage Ratio
 0.00 -106.77 0.00 -76.98 -392.29
Operating Cash Flow Coverage Ratio
 -3.50 -3.61 -4.88 -11.76 -7.04
Operating Cash Flow to Sales Ratio
 -343.85 -303.47 -3.68 -3.26 -4.84
Free Cash Flow Yield
-18514.61%-1697.75%-9.82%-5.25%-1.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.01 -0.18 -9.25 -14.70 -52.84
Price-to-Sales (P/S) Ratio
 1.86 18.04 37.43 62.90 286.30
Price-to-Book (P/B) Ratio
 0.27 1.35 -16.56 308.29 114.76
Price-to-Free Cash Flow (P/FCF) Ratio
 >-0.01 -0.06 -10.18 -19.06 -59.06
Price-to-Operating Cash Flow Ratio
 -0.06 -0.06 -10.18 -19.31 -59.21
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 0.22 >-0.01 1.32
Enterprise Value Multiple
 0.13 0.08 -12.94 -15.17 -56.06
Enterprise Value
 -12.94M -9.77M 2.14B 3.60B 10.15B
EV to EBITDA
 0.13 0.08 -12.94 -15.17 -56.06
EV to Sales
 -45.74 -19.01 37.07 62.04 284.26
EV to Free Cash Flow
 0.13 0.06 -10.08 -18.80 -58.64
EV to Operating Cash Flow
 0.13 0.06 -10.08 -19.04 -58.79
Tangible Book Value Per Share
 -0.03 -1.21 -18.25 -1.15 10.77
Shareholders’ Equity Per Share
 0.04 0.25 -15.04 2.23 13.51
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 <0.01
Revenue Per Share
 <0.01 0.02 6.65 10.95 5.41
Net Income Per Share
 -0.13 -1.87 -26.93 -46.86 -29.33
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.85 0.46 1.09 1.00 1.00
Research & Development to Revenue
 206.36 181.89 2.65 3.50 3.78
SG&A to Revenue
 53.67 -50.74 -0.90 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
Income Quality
 1.19 3.04 0.93 0.76 0.90
Currency in SEK